rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
1997-2-19
|
pubmed:abstractText |
We present the clinical case of a patient who was admitted to the intensive care ward with severe central nervous system symptoms and cardiovascular collapse within a week of starting sulphasalazine; in the absence of any other diagnosis, these symptoms were felt to be due to a previously unreported adverse effect of sulphasalazine.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0342-4642
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1096-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8923077-Aged,
pubmed-meshheading:8923077-Antirheumatic Agents,
pubmed-meshheading:8923077-Arthritis, Rheumatoid,
pubmed-meshheading:8923077-Diagnosis, Differential,
pubmed-meshheading:8923077-Female,
pubmed-meshheading:8923077-Humans,
pubmed-meshheading:8923077-Intensive Care,
pubmed-meshheading:8923077-Seizures,
pubmed-meshheading:8923077-Shock,
pubmed-meshheading:8923077-Sulfasalazine,
pubmed-meshheading:8923077-Ventricular Dysfunction, Left
|
pubmed:year |
1996
|
pubmed:articleTitle |
An unusual cause for collapse in a patient with arthritis.
|
pubmed:affiliation |
Department of Anaesthesia, Addenbrooke's Hospital, Cambridge, UK.
|
pubmed:publicationType |
Journal Article,
Case Reports
|